Amy DuRoss, Co-Founder and CEO
San Francisco, CA
Vineti creates the essential software solution to drive and scale personalized therapies, such as cell and gene therapy. Our leading Personalized Therapy Management (PTM) platform delivers simplicity, compliance, and patient safety to medicine’s most complex supply chain, providing the next-generation technology that advanced therapies need. Today’s personalized therapies require new technology strategies. Vineti combines leading software expertise with deep, first-hand biopharma experience to develop a cloud-based “platform of record” that ensures quality, scale, security, efficiency, traceability, and patient safety. The Vineti platform also provides actionable insights to continually optimize the therapy process, accelerating time to revenue and decreasing costs. Vineti partners with a range of small and large pharmaceutical developers, and offers the only independent platform to have been part of successful, expedited cell therapy approvals in the U.S. and EU. Vineti supports hundreds of medical centers worldwide and was named a World Economic Forum Technology Pioneer in 2019.

By using this website you agree to accept our Privacy Policy and Terms & Conditions